Introduction
The Rho related GTPases are involved in a variety of cellular processes and have a prominent role in the control of the actin cytoskeleton as well as cell growth and transformation (Fort, 1999; Ridley, 1999) . These small GTPases function as molecular switches: they are inactive when bound to GDP, and active when bound to GTP. The release of GDP and subsequent binding of GTP is catalyzed by guanine nucleotide exchange factors (GEFs) that function as GTPase activators. The GEFs from the Dbl family are Rho-speci®c exchange factors (Whitehead et al., 1997) . These proteins are characterized by a catalytic Dbl-Homology (DH) domain of about 200 aminoacids, usually followed by a pleckstrin homology (PH) domain (Stam and Collard, 1999) . There are over 40 proteins present in databases that contain a DH domain. About half of these putative exchange factors have been characterized as Rho protein activators. Some are speci®c for a single GTPase, while others can activate several Rho related proteins, but the speci®city of many Dbl-like GEFs remains to be established, especially in vivo (Aghazadeh et al., 1998; Stam and Collard, 1999) .
Beside their prominent role in the dynamics of the actin cytoskeleton, Rho GTPases are also important in the control cell proliferation, transformation and invasion (Fort, 1999) . Rho proteins are essential for Ras-induced oncogenic transformation and RhoA dominant negative mutants can block the entry into the cell cycle induced by active Ras (Olson et al., 1998) . Several Rho GTPases have been shown to have intrinsic although limited transforming properties by decreasing anchorage dependent cell growth, reducing cell contact inhibition or inducing tumor formation in nude mice (Fort, 1999) . Some Rho GTPases cooperate to induce focus formation in NIH3T3 cells, suggesting a cross-talk between Rhocontrolled pathways (Roux et al., 1997) . The activation of RhoA enhances tumor cell invasion (Fukushima et al., 2000) and RhoC is sucient to induce metastasis (Clark et al., 2000) . Several recent studies revealed a critical role of Rho GTPases in the control of cell proliferation suggesting that inhibiting these small molecules could be a new therapeutic strategy against cancer (Clark et al., 2000; Fukushima et al., 2000; Mira et al., 2000) .
Compared to the moderate activity of the Rho GTPases, some of the Dbl related exchange factors have high oncogenic transforming capacities (Stam and Collard, 1999; Whitehead et al., 1997) . The Dbl oncogene was originally isolated as a transforming gene when transfected in NIH3T3 cells (Eva and Aaronson, 1985) . Several other Dbl related proteins, such as Dbs, Ect-2, Lbc, Lfc, Lsc, Net, Ost and Tim were identi®ed from genomic or cDNA libraries as transforming proteins when transfected into NIH3T3 cells (Stam and Collard, 1999) . The transforming activity of Rho GEFs appears to be a common characteristic since other Dbl related proteins such as p115-RhoGEF that were isolated by dierent approaches also have transforming or invasive activities (Hart et al., 1996) . GEFs like Dbl (Janssen et al., 1999; Noguchi et al., 1988) , Bcr (McWhirter and Wang, 1997) and LARG (Fukuhara et al., 2000; Kourlas et al., 2000) are mutated in several human cancers, and others like aPIX/ARHGEF6 (Kutsche et al., 2000) in developmental disorders. The oncogenic activations of these GEFs are due to chromosomal rearrangements that modify the regulation of the genes or the sequence of the proteins themselves.
The distal region of chromosome 1 is one of the most frequently rearranged in the human genome (Slavotinek et al., 1999) . In particular band 1p36 which can be duplicated (Heilstedt et al., 1999) , translocated (Amler et al., 2000) or deleted (Caron et al., 2001; Hogarty et al., 2000; Ohira et al., 2000) . Rearrangements in this region are frequently associated with neuroblastoma (Hogarty et al., 2000) , but also leukemia and lymphoma as well as colorectal, hepatocellular or breast cancer (see http:// www.ncbi.nlm.nih.gov/CCAP/mitelsum.cgi for details). Therefore, it is of particular interest to determine the identity and the function of the genes in this region of human chromosome 1.
Here we report the characterization of GEF720, a new member of the Dbl family. GEF720 is related to p115Rho-GEF. The GEF720 is a 21 exon gene located on human chromosome 1 at locus 1p36.2 ± p36.3, immediately upstream of the gene encoding the surface receptor TNFRSF12/APO3/DR3 (Grenet et al., 1998) . Its mRNA is mainly expressed in brain. GEF720 behaves as a speci®c activator of mammalian RhoA in the Yeast Exchange Assay and directly activates guanine nucleotide exchange by RhoA in vitro. GEF720 overexpression induced an increase in the level of stress ®bers in REF52 ®broblastic cells, elicited transformation foci in NIH3T3 cells with a morphology characteristic of RhoA activation. Finally, as does activated RhoA, GEF720 inhibited nerve growth factor induced neurite outgrowth in the neuron-like PC12 cell line. Being part of the 1p36 chromosomal region involved in many human cancer, in particular neuroblastomas, GEF720 is a new candidate tumor regulator gene known to be present in this region.
Results

KIAA0720 encodes GEF720, a Dbl related protein
KIAA0720 is a 5' truncated cDNA from the HUGE protein database of the Kazusa DNA Research Institute (http://www.kazusa.or.jp/huge), predicted to encode a Dbl-related protein referred to as GEF720. We ®rst performed database searches and identi®ed a complete human cDNA of 3608 bp: Est AK024676, which contains an open reading frame of 912 amino acids with an ATG in a favorable Kozak's consensus context as well as a polyadenylation signal at the C-terminus (Figure 1 ). The expected molecular mass for GEF720 is 111 kDa. Protein analysis showed that the DH domain is located between aminoacids E249 and Q439 and the PH domain between Q490 and N590 (Figure 1 , shaded sequences). There is no other remarkable motif in the sequence of GEF720.
GEF720 is divergent from the other GEFs characterized so far: the closest known mammalian Dblrelated proteins are p115RhoGEF/Lsc (Glaven et al., 1996; Kozasa et al., 1998) and KIAA380/PDZRhoGEF (Fukuhara et al., 1999; Rumenapp et al., 1999) and there are no known homologues of GEF720 in other organisms such as Drosophila or C. elegans. The DH domain of GEF720 is only 33 and 28% identical to that of p115-and PDZRhoGEF respectively and the PH domain 21% and 19% identical respectively (Figure 2a ), while p115RhoGEF, Lsc and PDZ-RhoGEF DH domains are more than 50% identical (Fukuhara et al., 1999) . GEF720 thus constitutes a new stem in the Dbl-family, clearly distinct from the Lsc, PDZ-and p115RhoGEFs subgroup and from the p114-and p190RhoGEF, Lbc, Lfc/GEF-H1 subgroup (Figure 2b ), within which the GEFs share over 50% homology in their DH domains (Blomquist et al., 2000; Fukuhara et al., 1999) .
GEF720 is an exchange factor for RhoA
We next used the Yeast Exchange Assay to determine the speci®city of GEF720 and tested the ability of the exchange factor to activate RhoA, Rac1, Cdc42Hs and RhoG. We expressed the wild type GTPases fused to LexA DNA binding domain together with their respective eectors fused to GAD and tested the ability of GEF720 to induce the binding of the GTPases to their eectors. The û-galactosidase ®lter assays showed that GEF720 can activate RhoA in yeast, allowing the binding of the GTPase to its eector Rock, while it has no or little eect on Rac1, Cdc42Hs and RhoG (Figure 3a ) nor on Rac2 and 3 (data not shown). In the same experiment, the Cdc42Hs speci®c exchange factor aPIX (Manser et al., 1998) had no eect on the binding of RhoA to its eector.
Quantivative ONPG assays showed that the increase in û-galactosidase activity in the presence of GEF720 was 3.58-fold while in the same experiment, the exchange factor TrioD2 gave an increase of 4.37-fold (Figure 3b ). Given the high degree of similarity between RhoA and RhoB and RhoC (respectively 82 and 92% identical aminoacids), we assayed the activity of GEF720 on these two GTPases. In contrast to RhoA, GEF720 did not signi®cantly activate RhoB and C: we observed respectively a 1.45-and 1.47-fold increase in û-galactosidase activity, which was not signi®cantly dierent from the activity measured in the absence of exchange factor (Figure 3b ). This suggested that GEF720 is indeed a Rho protein exchange factor, with a speci®city toward RhoA.
To con®rm the results obtained in yeast and verify the direct activation of RhoA by GEF720, we performed in vitro exchange assays using puri®ed proteins. GST-fused RhoA and GEF720 DH domain were anity puri®ed from bacteria. RhoA was loaded with GDP and we examined the eect of GEF720 on the rate of nucleotide exchange by the GTPase. Addition of GEF720 DH domain did induce an acceleration of the GDP/GTP exchange reaction by RhoA ( Figure 3c ). We obtained similar results using a GEF720 construct containing both the DH and the PH domains (data not shown).
These results indicate that GEF720 is an exchange factor speci®c for RhoA.
GEF720 elicits stress fiber assembly in REF-52 fibroblasts
To investigate whether GEF720 could also activate RhoA in vivo, we transiently expressed the myc . We did not observe any lamellipodia or ®lipodia associated with the activation of Rac1, Cdc42Hs, RhoG (GauthierRouvieÁ re et al., 1998), TC10 (Murphy et al., 1999) , TCL or chp (Aronheim et al., 1998) . This suggested that GEF720 speci®cally activated endogenous RhoA protein in ®broblastic cells. To verify the activation of RhoA, we coexpressed GEF720 together with a fragment of kinectin (KID2: aa 1117 to 1356 of kinectin) that binds RhoA in the two hybrid system and inhibits RhoA-V14 in REF52 cells (Vignal et al. submitted) . As shown in Figure 4 , cells expressing GEF720 and GFP-KID2 did not exhibit any increase in the level of actin stress ®bers : in e ± g, compare the cell expressing only GEF720 (white arrow) to the two cells which express both GFP-KID2 and GEF720 (white stars).
These results show that GEF720 can induce stress ®ber assembly in REF-52 cells through the activation of endogenous RhoA.
GEF720 has a moderate transforming activity in NIH3T3 cells
A transforming activity has been described for several but not all Dbl related proteins (Stam and Collard, 1999; Whitehead et al., 1997) , while dominant active RhoA mutants were reported to have a weak transforming activity in NIH3T3 cells as compared to Ras (Khosravi-Far et al., 1995) . We determined the transforming activity of GEF720 using focus formation assays in NIH3T3 ®broblasts. Consistent with previous reports (Khosravi-Far et al., 1995) , we found that the dominant active mutant of RhoA had a weak transformation activity (980+79 foci per mg) as compared to Ras (15 600+900 foci per mg) (Figure 5a ). In the same assay, GEF720 had a transforming activity signi®cantly higher than RhoA (2070+81 foci per mg) but still about 7.5-fold lower that Ras-V12. The transforming activities measured for RhoA-V14 and GEF720 were within the range of the oncogenic potentials measured for dominant active RhoA and activated Vav and Vav-2 in similar experimental conditions (Schuebel et al., 1998) . The cells in GEF720-and RhoA-V14-induced foci were rounded and densely packed (Figure 5b ) as reported for other RhoA GEFs (Stam and Collard, 1999) , while Ras-V12 caused the appearance of larger, swirled foci with characteristic spindle shape cells (Figure 5b ). Like other members of the Dbl family (Stam and Collard, 1999; Whitehead et al., 1997) , GEF720 has a moderate transforming activity in NIH3T3 cells, transformed cells looking similar in GEF720 and RhoA-V14 induced foci. Together with the above results, these observations show that this new Dbl family member GEF720 is a direct activator of RhoA in vivo.
GEF720 in specifically expressed in brain and inhibits neurite outgrowth in PC12 neuron like cells
We next examined the expression pattern of GEF720 mRNA. We hybridized a 2.7 kb GEF720 probe (nt 578 to 3296 of the cDNA) to a Northern blot membrane for multiple mouse tissues. It revealed a single band around 3.7 kb, compatible with the size of the cDNA. Since GEF720 expression is brain speci®c, we analysed its activity in PC12 neuron-like cells. In this system, it has been reported previously that active RhoA inhibits neurite outgrowth triggered by NGFtreatment (Sebok et al., 1999) . In the presence of serum, PC12 cells expressing GEF720 maintained the same morphology as untransfected cells (Figure 6b , panels a and b). We obtained the same results upon RhoA-V14 expression (data not shown). However, after serum starvation and NGF treatment, 95% of GEF720 expressing cells showed a spread morphology but failed to produce neurite outgrowth, while non expressing cells underwent neuronal dierentiation and presented long extensions (Figure 6b, panels c and d) .
In similar conditions, we also observed the inhibition of neurite outgrowth in PC12 cells expressing RhoA-V14 (Figure 6b , panels d and e).
This shows that the expression of GEF720 can in fact interfere with neuronal dierentiation through its ability to activate endogenous RhoA.
GEF720 gene is located on human chromosome 1 at 1p36.2 ± 1p36.3
Database searches revealed a partially ordered and sequenced genomic fragment of 102 681 pb from human chromosome 1 (GeneBank reference NT_022059). This fragment contains the whole GEF720 gene, except exon V which lies within a non sequenced gap. The gene is made of 21 exons encompassing at least 27 kilobases (Figure 7a ). GEF720 gene is at the 1p36.23 ± 1p36.31 junction, 5' upstream of the Tumor Necrosis Factor Receptor Super Family (TNFRSF) 12 gene, a 5 kb gene also termed DR3, WSL1, LARD and APO3 (Marsters et al., 1998) , and downstream of the FLJ20430 putative protein gene and the p53 related Tumor Protein 73 (TP73) gene (Stiewe and Putzer, 2000) (Figure 7b) . Interestingly, while all Est cDNAs present in databases such as AK024676 ®nish just after the consensus polyadenylation signal, KIAA0720 displays a 1 kb extension at the 3' end which overlaps the ®rst exon of the TNFRSF12 gene (Figure 7c ). This suggests that KIAA0720 corresponds to a mRNA which was not matured properly and indicates that the two genes encoding GEF720 and TNFRSF12 are very close on chromosome 1. The chromosomal rearrangements in the 1p36.2 ± 36.3 chromosomal region involving TP73 and TNFRSF12 genes are frequently observed in dierent cancers and in particular in neuroblastoma (Grenet et al., 1998; Nomoto et al., 2000; Hogarty et al., 2000) . GEF720, a new member of the Dbl family with transforming properties, that maps between TP73 and TNFRSF12, thus appears as an interesting candidate gene whose deregulation might prove important for the progression toward neuroblastoma. 
Discussion
We have characterized a new exchange factor from the Dbl family: GEF720. We used the Yeast Exchange Assay and in vitro biochemical exchange assays and established that GEF720 can directly catalyse nucleotide exchange on RhoA, as suggested by its homology to PDZ-RhoGEF and p115RhoGEF. GEF720 was not active on RhoB, RhoC, RhoG, Rac1-3 and Cdc42Hs. Expression of GEF720 in REF-52 ®broblastic cells elicited an increase in the level of actin stress ®bers, characteristic of RhoA activation and when overexpressed in NIH3T3 cells, GEF720 induced the formation of transformation foci. GEF720 mRNA is expressed almost exclusively in brain and as shown for RhoA activation, it inhibited NGF-induced neurite outgrowth. GEF720 is encoded by a gene located on chromosome 1 next to DR3/APO3 at 1p36.2 ± 1p36.3, a region prone to multiple rearrangements in various human cancers and in developmental disorders. These in vitro and in vivo studies show that GEF720 is a new brain exchange factor speci®c for RhoA.
Although Rho-related proteins are essential regulators of many signal transduction pathways (Ridley, 1999) , how these GTPases are activated in the cell still remains largely unknown. There are more than 40 GEFs identi®ed and their activities on the 18 Rhorelated GTPases is to be established. To identify and characterize novel exchange factors, we used the consensus for the catalytic DH domain and searched for novel Dbl related proteins in databases. We found a new putative Rho exchange factor, GEF720. GEF720 is related to the p115RhoGEF subgroup of RhoA exchange factors, that contains three closely related GEFs: p115RhoGEF, KIAA380/PDZ-Rho-GEF and lsc which share over 50% identity within their DH-PH domains (Fukuhara et al., 1999) . Another subgroup related to GEF720 are the proteins similar to p114RhoGEFF: p114-, p190RhoGEF, lbc and lfc, which are also highly homologous in their DH-PH domains (Blomquist et al., 2000) . Nevertheless, GEF720 is clearly divergent from these proteins and de®nes a new branch of RhoA speci®c exchange factors.
The variety of intracellular pathways controlled by the Rho GTPases is re¯ected by a still growing family of Dbl related proteins. In particular, 15 Dbl-related exchange factors active on RhoA have been characterized so far, that have ubiquitous or tissue speci®c expression patterns and that can activate only RhoA or several Rho GTPases: GEF720 (this work), p114Rho-GEF (Blomquist et al., 2000) , KIAA380/PDZ-Rho-GEF (Fukuhara et al., 1999; Rumenapp et al., 1999) , GEF337 ( De Toledo et al., 2000) , p115RhoGEF/Lsc Figure 4 GEF720 induces RhoA dependent stress ®ber assembly in ®broblasts. REF52 cells were transfected with constructs expressing myc-tagged RhoA-V14 (a) or GEF720 (c,e) and GFP-tagged KID2 (g), actin was visualized with TRITC-phalloidin (b,d,f). Scale bar : 10 mm GEF720, a new Dbl-related RhoA activator, maps to 1p36 M De Toledo et al (Kozasa et al., 1998 ), p190RhoGEF (van Horck et al., 2000 , Vav, Vav-2 and Vav-3 (Han et al., 1997; Movilla and Bustelo, 1999; Schuebel et al., 1998) , TrioD2 (Bellanger et al., 1998 ), Ect2 (Tatsumoto et al., 1999 , Dbs (Whitehead et al., 1999) , Ost (Horii et al., 1994) , mNET , GEF-H1 and Lbc (Glaven et al., 1996; Ren et al., 1998) . There are comparatively many less exchange factors identi®ed for Rac, Cdc42, RhoG or the other Rho GTPases. This may re¯ect the fact that RhoA functions as a common intracellular switch towards which a broad variety of signaling cascade converge, involving for instance G protein coupled receptors (Fukuhara et al., 1999) , integrins (Miranti et al., 1998) , or interleukin receptors (Singh et al., 1999) . The organization of the cytoskeleton is indeed regulated through a crosstalk between the antagonistic Rac and Rho pathways (Moorman et al., 1999; Sander et al., 1999) . These reports show that the activation of RhoA does not result in Rac1 inactivation and that RhoA can induce modi®cations of the actin cytoskeleton even though Rac1 and Cdc42Hs remain active. On the other hand, activation of Rac1 and Cdc42Hs results in the concomitant inactivation of RhoA (Moorman et al., 1999; Sander et al., 1999 and references therein) . These studies suggest that the action of RhoA is dominant on Rac1 and Cdc42Hs. In such a context, the regulation of the balance between these GTPases would require ubiquitous GEFs to ensure a basal activation of Rac1 and Cdc42Hs, while more tissue or signal speci®c GEFs would activate RhoA, thereby inhibiting the action of Rac1 and Cdc42. This may explain the many exchange factors identi®ed for RhoA compared to Rac1 and Cdc42Hs. Our understanding of these RhoA dependent signaling cascades relies on the identi®cation of the speci®c upstream activators of the exchange factors. In the case of neuronal dierentiation, RhoA appears to be involved in dierent steps of NGF-induced neuronal dierentiation (Sebok et al., 1999) suggesting that dierent RhoA GEFs may be sequentially active or that the same GEF may be activated through dierent cascades. Identifying the proteins that interact with GEF720, a GEF speci®cally expressed in adult and fetal brain, should provide new insights in understanding the role of RhoA in controlling neural dierentiation pathways.
As shown for Lbc, Lsc and Tim, overexpression of the full length GEF720 protein can induce focus formation in NIH3T3 cells, without requiring truncation or post-translational modi®cation of the protein as reported for Dbl, Net1, Vav, Vav-2 or Ect2 (Stam and Collard, 1999; Whitehead et al., 1997) . Several members of the Dbl family possess a high oncogenic activity. The activation of these cellular protooncogenes often occurs through a speci®c mutation or a chromosomal rearrangement event which results in deregulated activity of the protein (Stam and Collard, 1999) . Interestingly GEF720, that exhibits a slight transforming potential, is located at 1p36.2 ± p36.3 between TP73 and TNFRSF12/DR3/APO3 genes, the polyadenylation signal of GEF720 mRNA being only 846 nucleotides upstream of the ®rst exon of TNFRSF12. The distal part of the short arm of chromosome 1 is among the chromosomal regions most aected by rearrangements; chromosomal alterations within the 1p36 region are often involved in various human cancers (information at http:// www.ncbi.nlm.nih.gov/CCAP/mitelsum.cgi) as well as various developmental disorders and in¯ammatory diseases (Cho et al., 2000; Knight-Jones et al., 2000; Slavotinek et al., 1999) . There has been a great interest in identifying genes located in this chromosomal region to get better understanding of the etiology of the associated diseases. Loss of heterozygosity in the 1p36 region has been associated with most neuroblastoma (Grenet et al., 1998; Hogarty et al., 2000; Ohira et al., 2000) but also lung cancer (Nomoto et al., 2000) , breast carcinoma (Ejeskar et al., 2000) or prostate cancer (Ahman et al., 2000) etc. In particular, GEF720 gene is located in a 1 megabase consensus at 1p36.3 which is often deleted in primary neuroblastoma (Hogarty et al., 2000) and which also contains the two genes TNFRSF12/DR3/APO3 (Grenet et al., 1998) and TP73 (Kaghad et al., 1997) . There has been a great eort in identifying new genes lying in this 1p36 rearranged region to try and elucidate more precisely the molecular mechanisms controlling the various disorders associated with genetic abnormalities in this region and in particular the frequent loss of heterozygosity observed in primary neuroblastoma (Hogarty et al., 2000) . In that prospect, GEF720 which is speci®cally expressed in brain and belongs to the Dbl family, appears as an interesting candidate gene in the control of neuroblastoma progression. Further study on the structure of GEF720 gene and expression of the protein should help in understanding a potential link of RhoA activation with neuroblastoma progression.
Materials and methods
Plasmids and sequence analysis KIAA0720 cDNA encoding GEF720 (GenBank accession number AB018263) was kindly provided by Dr T Nagase (Kazusa DNA Research Institute, Chiba, Japan). The Sal1-BamH1 fragment of KIAA0720 (containing GEF720 aminoacids from L49 to V912) was myc tagged in plasmid pRs426MET (Tirode et al., 1997) for yeast expression and in plasmid pRcCMV (In Vitrogen) for tissue culture cell expression. GEF720 DH domain (aminoacids L249 to A445) was fused to GST in pGEX-5X2 (Pharmacia). RhoB was fused to LexA in plasmid pVJL12 (Tirode et al., 1997) and pLexRhoC was a gift from G Zalcman (Institut Curie, Paris, France). All the other yeast expression vectors have been described previously . Sequence analysis were performed using the NCBI facilities at http:// www.ncbi.nlm.nih.gov. Protein sequences were aligned using MULTALIN; distance matrixes were computed and used to draw a similarity tree using ClustalW and Treeview (refs in Vignal et al., 2000) .
Yeast exchange assay
The yeast exchange assay was performed as described . Brie¯y, TAT7 or cdc24 ts 12.1 yeasts expressing the LexA fused wild type (wt) GTPases and GAD-AD (GAD) fused eectors, Rock for RhoA, Kinectin for Rac1 and RhoG and PAK for Cdc42Hs , were transformed with the empty pRs426MET vector or the same plasmid expressing the indicated exchange factors. After selection, the transformants were assayed for û-galactosidase activity by ®lter or colorimetric assay as described .
In vitro guanine nucleotide exchange assay GST-fused GTPases and exchange factors were puri®ed from E. coli as described . For the exchange assay, GDP-loaded RhoA (1 mM) was incubated at 308C in exchange buer (50 mM HEPES pH 7.5, 100 mM KCl, 2 mM MgCl 2 , 1 mM DTT, 10 mM GTP-gS and 1 mCi GTP- [g 35 S] ) in the presence of 1 mM GST-GEF720 or GST. After 0.5, 5 and 15 min, aliquots of the reaction were ®ltered on nitrocellulose, rinsed with stop buer (50 mM Tris pH 7.5, 10 mM MgCl 2 ) and the amount of GTP- [g 35 S] bound to the GTPase was measured.
Tissue culture cell, immunofluorescence and transformation assays
Rat embryo ®broblasts ) were cultured at 378C in the presence of 5% CO 2 in DMEM supplemented with 10% fetal calf serum (FCS). PC12 cells were cultured at 378C in the presence of 5% FCS and 10% horse serum (HS). REF-52 cells were plated onto 12 mm glass coverslips and PC12 cells were plated on the same coverslips coated with collagen. Both cell types were transfected using the lipofectamine plus methods (Life Technologies). Four hours after transfection, the medium was replaced with fresh medium. For PC12 dierentiation, 48 h after transfection, cells were placed in DMEM with 0.5% HS and 50 ng/ml Nerve Growth Factor (NGF) (Promega). Cells were ®xed for immuno¯uorescence for 5 min in 3.7% formalin in PBS, permeabilized for 2 min with 0.1% Triton X-100 in PBS and incubated in 0.1% Bovine Serum Albumine (BSA) in PBS. The myc-tagged proteins were detected using anti-myc 9E10 monoclonal antibody followed by anti-mouse 7-Amino-4-MethylCoumarin-3-Acetic acid (AMCA) conjugated antibody (1 : 50 dilution, Amersham). Actin ®laments were stained using a solution of TetramethylRhodamine IsoThioCyanate (TRITC)-phalloidin (0.5 u/ml, Sigma). Cells were washed in PBS, mounted in Mowviol (Aldrich) and observed under a DMR Leica microscope using a 636 planapochromat lens. Images were recorded using a micromax 1300Y/HS camera (Princeton Instruments Inc, USA) using the Metamorph acquisition software, transferred to Adobe Photoshop and printed on an Epson Color 750 printer. All transfections were repeated at least three times and at least 100 transfected cells were examined. Transformation assays were performed essentially as described (Schuebel et al., 1998) . Brie¯y, NIH3T3 cells were grown at 378C in the presence of 5% CO 2 in DMEM supplemented with 10% (FCS). Cells were transfected as described above with plasmids expressing Ha-tagged Ras-V12 (2, 10 50 or 500 ng per 60 mm dish), myc-tagged RhoA-V14, GEF720 or with the empty pRcCMV vector (5, 200, 500 or 1000 ng per 60 mm dish). When cells reached con¯uency, the amount of serum was reduced to 4%. Two weeks after transfection, dishes were stained with 0.4% crystal violet in 30% methanol to visualize transformed foci. For each plasmid concentration, three to four dishes were counted.
RNA extraction and Northern blotting
Total RNA was prepared from 6 week adult Swiss mice as described (Chomczynski and Sacchi, 1987) . Forty mg total RNA of each tissue were resolved on a classical 3.7% formaldehyde phosphate-buered 1.2% agarose gel and transferred onto nitrocellulose membranes and hybridized as described (Coulon et al., 1999) with the a 32 P-dCTP labeled Sal1-BamH1 fragment of KIAA0720 and S26 ribosomal protein cDNA (Vincent et al., 1992) . After washing, blots were exposed on Kodak Biomax MR ®lm or phosphorimager cassettes.
